Vol. 9 No. 1 (2022): January-December 2022

Editorial

New trends in clinical trials—between complexity and the need for renewal

Celeste Cagnazzo

42-44
- PDF
- ePub
- html
Introducing the “How to …” review article series

Giacomo Bellani, Giulio Zuanetti

10
- PDF
- ePub
- html
Altmetrics, Beamplots, Plum X Metrics and friends: discovering the new waypoints in the Science Metrics roadmap

Valeria Scotti

1-2
- PDF
- ePub
- html

Review

A roadmap for building your scientific reputation on social media

Vittorio Iacovella

87-91
- PDF
- ePub
- html

Point of view

What will remain of the Impact Factor?

Valeria Scotti

45-46
- PDF
- ePub
- html
Guideline proposal for pharma companies to manage pharmacovigilance activities in digital media

Daniela Bernardini, Ilenia Bocchi, Stefano Bonato, Davide Bottalico, Valentina Calderazzo, Carmela Casino, Gian Nicola Castiglione, Carla Cottone, Stefania Dellon, Ilaria Grisoni, Amanda Mattavelli, Giacomo Pirisino, Silvia Romano, Grazia Sirizzotti, Lisa Stagi, on behalf of the SIMeF Working Group

21-28
- PDF
- ePub
- html
A mixed reality telemedicine system for collaborative ultrasound diagnostics and ultrasound-guided interventions

Stefan Maas, Peter Kopacsi, Peter Kovacs, Arnaud Bosteels

15-20
- PDF
- ePub
- html

Original research article

Model for estimating the impact of healthcare costs in non-hospitalized Covid-19 patients treated with remdesivir

Matteo Ruggeri, Alessandro Signorini, Silvia Caravaggio, Marco Falcone, Giovanni Di Perri

114-121
- PDF
- ePub
- html
Savings associated with therapeutic appropriateness for patients with relapsed refractory multiple myeloma and high cytogenetic risk diagnosed by FISH test

Rossella Bitonti, Federica Demma, Massimiliano Rea, Gianluca Furneri

105-111
- PDF
- ePub
- html
- Supplementary material
Cost-utility analysis of brigatinib compared to alectinib in the treatment of ALK-positive NSCLC in patients previously not treated with an ALK inhibitor

Roberto Ravasio, Holly Cranmer, Izzie Kearns , Raffaella Viti, Simone Corinti

92-104
- PDF
- ePub
- html
Cost analysis comparison of rurioctocog alfa pegol compared to turoctocog alfa pegol in the prophylaxis of Haemophilia A in Italy

Federica Demma, Pierpaola Arpa

36-42
- PDF
- ePub
- html
Psoriasis at the time of COVID-19: results of an Italian survey on patients and caregivers

Valeria Dealessi, Giovanni Gigante, Claudia Leporati, Ugo G. Viora

29-35
- PDF
- ePub
- html
Health Policy Brief: i pilastri dell’Engagement in Emofilia

Guendalina Graffigna, Serena Barello, Caterina Bosio, Chiara Biasoli, Andrea Buzzi, Cristina Cassone, Luigi Ambroso, Patrizia Di Gregorio, Lorenzo Farace, Paola Giordano, Renato Marino, Irene Ricca, Angiola Rocino

3-9
- PDF
- ePub
- html

How to

How to insert a PICC: practical tips for the intensive care physician

Stefano Elli, Giacomo Bellani, Alberto Lucchini

11-14
- PDF
- ePub
- html

Focus on the management of critical bleeding

Classical and Point-of-Care tests in severe hemorrhage management

Paolo Simioni

47-51
- PDF
- ePub
- html
Plasma, platelets and cryoprecipitates therapies

Vanessa Agostini

52-57
- PDF
- ePub
- html
Sepsis-induced coagulopathy and disseminated intravascular coagulation

Antonino Giarratano

58-60
- PDF
- ePub
- html
Major obstetric hemorrhage management

Maria Grazia Frigo

61-65
- PDF
- ePub
- html
Management of bleeding in cardiac surgery patients

Marco Ranucci

66-69
- PDF
- ePub
- html
Coagulopathy and hemorrhage management in major abdominal surgery

Cristiano Piangatelli

70-72
- PDF
- ePub
- html
Coagulopathy and hemorrhage management in cirrhotic patients

Giandomenico Biancofiore

73-76
- PDF
- ePub
- html
Trauma-induced coagulopathy management

Maria Grazia Bocci

77-82
- PDF
- ePub
- html

Case report

Emicizumab in hemophilia A with inhibitors: clinical and economic impact of its use in a Cuban patient

Dunia Castillo-Gonzàles, Irianys Álvarez Sardiñas, Consuelo Macías Abraham, Alex G. Muñoz Bedoya

83-86
- PDF
- ePub
- html

Correspondence

Implementation of telemedicine and home medication dispensing for rheumatoid arthritis patients in Sicily: opportunities beyond the pandemic

Giovanni Pistone

112-113
- PDF
- ePub
- html

Vol. 9 No. 1 (2022): January-December 2022

Full Issue

Editorial

New trends in clinical trials—between complexity and the need for renewal

Introducing the “How to …” review article series

Altmetrics, Beamplots, Plum X Metrics and friends: discovering the new waypoints in the Science Metrics roadmap

Review

A roadmap for building your scientific reputation on social media

Point of view

What will remain of the Impact Factor?

Guideline proposal for pharma companies to manage pharmacovigilance activities in digital media

A mixed reality telemedicine system for collaborative ultrasound diagnostics and ultrasound-guided interventions

Original research article

Model for estimating the impact of healthcare costs in non-hospitalized Covid-19 patients treated with remdesivir

Savings associated with therapeutic appropriateness for patients with relapsed refractory multiple myeloma and high cytogenetic risk diagnosed by FISH test

Cost-utility analysis of brigatinib compared to alectinib in the treatment of ALK-positive NSCLC in patients previously not treated with an ALK inhibitor

Cost analysis comparison of rurioctocog alfa pegol compared to turoctocog alfa pegol in the prophylaxis of Haemophilia A in Italy

Psoriasis at the time of COVID-19: results of an Italian survey on patients and caregivers

Health Policy Brief: i pilastri dell’Engagement in Emofilia

How to

How to insert a PICC: practical tips for the intensive care physician

Focus on the management of critical bleeding

Classical and Point-of-Care tests in severe hemorrhage management

Plasma, platelets and cryoprecipitates therapies

Sepsis-induced coagulopathy and disseminated intravascular coagulation

Major obstetric hemorrhage management

Management of bleeding in cardiac surgery patients

Coagulopathy and hemorrhage management in major abdominal surgery

Coagulopathy and hemorrhage management in cirrhotic patients

Trauma-induced coagulopathy management

Case report

Emicizumab in hemophilia A with inhibitors: clinical and economic impact of its use in a Cuban patient

Correspondence

Implementation of telemedicine and home medication dispensing for rheumatoid arthritis patients in Sicily: opportunities beyond the pandemic

Browse

banners150

Vol. 9 No. 1 (2022): January-December 2022

Full Issue

Editorial

Review

Point of view

Original research article

How to

Focus on the management of critical bleeding

Case report

Correspondence

Sign up

Browse

banners150